Free Trial

Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Kate Stalter
About The Author

Kate Stalter

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Gilead Sciences (GILD)
4.9232 of 5 stars
$112.691.9%2.80%22.45Moderate Buy$117.17
Medtronic (MDT)
4.8436 of 5 stars
$97.632.3%2.91%26.90Moderate Buy$100.94
Pfizer (PFE)
4.8714 of 5 stars
$27.371.1%6.29%14.56Hold$28.41
Eli Lilly and Company (LLY)
4.9907 of 5 stars
$840.462.5%0.71%54.93Moderate Buy$938.94
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Related Videos

AI vs. Wall Street: 5 Names It Loves Right Now
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines